MagazinePhysician Magazine Request Business Info

Today's News - New Market Opening! AUSTRALIA AND NEW ZEALAND: Interviews for the first exclusive providers have begun!

YOUR PATIENTS ARE ASKING

KNOW THE RIGHT ANSWER

  • Level 1 FDA, double blind, randomized, placebo controlled, multi-sight clinical trial
  • First and only device ever approved by the FDA for the circumferential reduction of the waist, hips, thigh, and arms
  • FDA trials proved 3-9 inches in 2 weeks
  • Up to 40 inches (101cm) or more with additional treatments
  • LDL cholesterol Levels lowered 13% in 2 weeks as verified by FDA clinical trials
  • Enhanced Muscle Performance
  • Recovery and Rapid Cellular Regeneration
  • Reduction of inflammation
  • ZERO pain

This is breakthrough science. LifeForce International's Physician Support and Education Program is here to help medical professional understand low level (cold) laser mechanisms of action and learn about this leading edge, clinically proven technology and how it might help you support your patients' health goals. No doubt you will be surprised and excited by the science.

Click here to view physician's Zerona webinar with world's leading low level laser scientist

MECHANISMS OF LOW LEVEL LIGHT THERAPY
Michael R. Hamblin

Harvard Medical School, Massachusetts General Hospital

Click here to view
Reduction in Cholesterol and Triglyceride Serum Levels Following Low-Level Laser Irradiation: A Noncontrolled, Nonrandomized Pilot Study
Robert F. Jackson, MD; Greg C. Roche; Kevin Wisler, MD

The American Journal of Cosmetic Surgery

Click here to view
FAT LIQUEFACTION: EFFECT OF LOW-LEVEL LASER ENERGY ON ADIPOSE TISSUE
Robert F. Jackson, MD; Greg C. Roche; Kevin Wisler, MD

American Society of Plastic and Reconstructive Surgery

Click here to view
Low-Level Laser Therapy as a Non-Invasive Approach for Body Contouring
Robert F. Jackson, MD; Joug D. Dedo, MD; Greg C. Roche, MD; David I. Turok, and Ryan J. Maloney, BS

A Randomized, Controlled Study Lasers in Surgery Medicine 41: 799-809 (2009)

Click here to view
ADIPOSE TISSUE AS AN ENDOCRINE ORGAN
Sandra Galica, Jon S. Oakhilla, Gregory R. Steinberga

Journal of Molecular and Cellular Endocrinology, St. Vincent's Institute of Medical Research and Department of Medicine, University of Melbourne, McMaster University, Department of Medicine

Click here to view
ADIPOKINES: THE MISSING LINK BETWEEN INSULIN RESISTANCE AND OBESITY
B. Antuna-Puente, B. Fevec, S. Fellahi, J.-P. Bastard

Elsevier Masson – Diabetes & Metabolism

Click here to view
DIABETES MELLITUS, INFLAMMATION, OBESITY: PROPOSED TREATMENT PATHWAYS FOR CURRENT AND FUTURE THERAPIES
Travis E Sonnett, Terri L Levien, Brian J Gates, Jennifer D Robinson, and R Keith Campbell

The Annals of Pharmacotherapy

Click here to view
ZERONA TREATMENTS. LEADING SCIENTIST SPEAKS TO DOCTORS
Scientist Ryan J. Maloney, explains the scientific empirical evidence of ZERONA in conversation with doctors.

Webinar. Session recorded

Click here to view

Request Business Information


Loading...